SE466450B - Nya aminoacylater av glycerolacetal, foerfarande foer framstaellning av dessa och en terapeutisk komposition - Google Patents

Nya aminoacylater av glycerolacetal, foerfarande foer framstaellning av dessa och en terapeutisk komposition

Info

Publication number
SE466450B
SE466450B SE8802162A SE8802162A SE466450B SE 466450 B SE466450 B SE 466450B SE 8802162 A SE8802162 A SE 8802162A SE 8802162 A SE8802162 A SE 8802162A SE 466450 B SE466450 B SE 466450B
Authority
SE
Sweden
Prior art keywords
formula
integer
acid
group
paf
Prior art date
Application number
SE8802162A
Other languages
English (en)
Swedish (sv)
Other versions
SE8802162D0 (sv
SE8802162L (sv
Inventor
C Broquet
P Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE8802162D0 publication Critical patent/SE8802162D0/xx
Publication of SE8802162L publication Critical patent/SE8802162L/xx
Publication of SE466450B publication Critical patent/SE466450B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8802162A 1987-06-12 1988-06-09 Nya aminoacylater av glycerolacetal, foerfarande foer framstaellning av dessa och en terapeutisk komposition SE466450B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878713745A GB8713745D0 (en) 1987-06-12 1987-06-12 Aminoacylates of glycerol

Publications (3)

Publication Number Publication Date
SE8802162D0 SE8802162D0 (sv) 1988-06-09
SE8802162L SE8802162L (sv) 1988-12-13
SE466450B true SE466450B (sv) 1992-02-17

Family

ID=10618794

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802162A SE466450B (sv) 1987-06-12 1988-06-09 Nya aminoacylater av glycerolacetal, foerfarande foer framstaellning av dessa och en terapeutisk komposition

Country Status (33)

Country Link
US (1) US4921865A (nl)
JP (1) JPH0615540B2 (nl)
KR (1) KR960005153B1 (nl)
AR (1) AR245121A1 (nl)
AT (1) AT396236B (nl)
AU (1) AU621298B2 (nl)
BE (1) BE1000700A4 (nl)
CA (1) CA1337297C (nl)
CH (1) CH674516A5 (nl)
DE (1) DE3819829C2 (nl)
DK (1) DK319188A (nl)
DZ (1) DZ1215A1 (nl)
ES (1) ES2009283A6 (nl)
FI (1) FI90421C (nl)
FR (2) FR2616326B1 (nl)
GB (1) GB8713745D0 (nl)
GR (1) GR1000889B (nl)
HK (1) HK77191A (nl)
IE (1) IE61447B1 (nl)
IN (1) IN172782B (nl)
IT (1) IT1218067B (nl)
LU (1) LU87235A1 (nl)
MA (1) MA21298A1 (nl)
MY (1) MY103577A (nl)
NL (1) NL192521C (nl)
NO (1) NO170632C (nl)
NZ (1) NZ224936A (nl)
OA (1) OA08879A (nl)
PT (1) PT87689B (nl)
SE (1) SE466450B (nl)
SG (1) SG73191G (nl)
TN (1) TNSN88057A1 (nl)
ZA (1) ZA884024B (nl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035178A (en) * 1976-08-31 1977-07-12 Fmc Corporation Herbicidal 1,3-dioxanes
IN146343B (nl) * 1976-08-31 1979-05-05 Fmc Corp
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters

Also Published As

Publication number Publication date
KR960005153B1 (ko) 1996-04-22
SE8802162D0 (sv) 1988-06-09
NO170632C (no) 1992-11-11
NZ224936A (en) 1990-03-27
TNSN88057A1 (fr) 1990-07-10
IE881752L (en) 1988-12-12
AR245121A1 (es) 1993-12-30
FI882705A (fi) 1988-12-13
IE61447B1 (en) 1994-11-02
FR2616432B1 (fr) 1990-05-11
DK319188D0 (da) 1988-06-10
SG73191G (en) 1991-11-22
NO882564D0 (no) 1988-06-10
FR2616432A1 (fr) 1988-12-16
JPS6413085A (en) 1989-01-17
PT87689B (pt) 1992-09-30
DZ1215A1 (fr) 2004-09-13
ATA152988A (de) 1992-11-15
FI882705A0 (fi) 1988-06-08
DE3819829A1 (de) 1988-12-22
FR2616326A1 (fr) 1988-12-16
FI90421C (fi) 1994-02-10
MA21298A1 (fr) 1988-12-31
IT1218067B (it) 1990-04-12
ES2009283A6 (es) 1989-09-16
AU621298B2 (en) 1992-03-12
CA1337297C (en) 1995-10-10
NO170632B (no) 1992-08-03
ZA884024B (en) 1989-02-22
MY103577A (en) 1993-08-28
FI90421B (fi) 1993-10-29
IN172782B (nl) 1993-11-27
NL8801484A (nl) 1989-01-02
CH674516A5 (nl) 1990-06-15
GR1000889B (el) 1993-03-16
DK319188A (da) 1989-02-03
GB8713745D0 (en) 1987-07-15
JPH0615540B2 (ja) 1994-03-02
PT87689A (pt) 1988-07-01
DE3819829C2 (de) 1993-10-21
OA08879A (fr) 1989-10-31
GR880100363A (en) 1989-03-08
NO882564L (no) 1988-12-13
HK77191A (en) 1991-10-11
KR890000471A (ko) 1989-03-14
AT396236B (de) 1993-07-26
FR2616326B1 (fr) 1989-12-01
US4921865A (en) 1990-05-01
BE1000700A4 (fr) 1989-03-14
NL192521C (nl) 1997-09-02
IT8820940A0 (it) 1988-06-10
AU1756288A (en) 1988-12-15
SE8802162L (sv) 1988-12-13
NL192521B (nl) 1997-05-01
LU87235A1 (fr) 1988-12-13

Similar Documents

Publication Publication Date Title
EP0515684A1 (en) Inhibitor of denatured ldl formation
US4596809A (en) Substituted 1,8-naphthyridinones, useful as anti-allergic agents
DE3701344A1 (de) Neue thieno-1,4-diazepine
SE466450B (sv) Nya aminoacylater av glycerolacetal, foerfarande foer framstaellning av dessa och en terapeutisk komposition
KR900006118B1 (ko) 4-퀴놀론 유도체의 제법
EP0289365A2 (en) Novel nitrogen-containing compound
EP0255028A2 (de) Neue 1,4-Benzodiazepine, ihre Herstellung und Verwendung als PAF Antagonisten
US5134151A (en) 2-picolylamine derivatives
CA1261844A (en) 3-(n-alkylcarbamoyloxy)-2-alkyloxypropyl-2- substituted ethyl phosphate compounds
JPS58113140A (ja) ナフトキシアルキル化合物、その製造法およびそれからなる抗炎症剤
US4477446A (en) 1-Benzazepines and their pharmaceutical uses
GB2205833A (en) Aminoacylates of glycerol acetal
JPH01151583A (ja) ギンコライド誘導体、その製造方法及びそれを含有する医薬組成物
JPH0631228B2 (ja) 新規な５―（ω―アンモニオアシルオキシメチレン）テトラヒドロフラン類及びテトラヒドロチオフェン類、それらの製造法並びにそれらを含有する抗ＰＡＦ剤
DE69911946T2 (de) Phosphonsäure-diester-derivate
SE505239C2 (sv) Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa
RU1795971C (ru) Способ получени пиразолопиридинового соединени или его соли
FI81562B (fi) Foerfarande foer framstaellning av syraadditionssalter av 1,3-bis(dimetylamino)-2-propyl-4-klorfenoxiacetat och anvaendningen av dessa som laekemedel.
JPH01500270A (ja) ５‐ヘテロ‐またはアリール‐置換された‐イミダゾ［２，１‐ａ］イソキノリン類
JPS5924975B2 (ja) スルフアミル安息香酸類の製法
KR900004829B1 (ko) 치환된 1,8-나프티리딘온 및 이의 제조방법
JP2955768B2 (ja) 新規なジアゾシン誘導体
DK163661B (da) 2,5-pyrrolidindionderivater og farmaceutisk acceptable syreadditionssalte deraf
SU1319522A1 (ru) 2,9-Дифенил-6,12-бис-(метоксикарбонил)-1,8-диоксадиспиро(4,1,4,1)додека-2,9-диен-4,11-дион, про вл ющий противовоспалительную активность
JPH01180821A (ja) 肝疾患治療・予防剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8802162-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8802162-1

Format of ref document f/p: F